The mature T cell receptor (TCR) repertoire is shaped by positive-and negative-selection events taking place during T cell development. These events are regulated by interactions between the TCR and major histocompatibility complex molecules presenting self-peptides. It has been shown that many antagonist peptides are efficient at mediating positive selection. In this study we analyzed the effects of a transgene encoding an antagonist peptide (inf luenza NP34) that is presented by H-2D b in a Tap-1-independent fashion in mice expressing the inf luenza NP68-specific TCR F5. We find that the transgenic peptide does not mediate positive or negative selection in F5 ؉ Tap-1 ؊͞؊ mice, but inhibits maturation of CD8 ؉ single positive thymocytes in F5 ؉ Tap-1 ؉ mice without inducing signs of negative selection. We conclude that antagonism of antigen recognition occurs not only at the level of mature T cells but also in T cell development.
Thymocytes are subjected to positive-and negative-selection events during their development (1) . Positive selection involves the differentiation of immature thymocytes with a T cell receptor (TCR) specificity restricted to self-major histocompatibility complex (MHC) into mature, functional T cells. Negative selection is the elimination of thymocytes with a TCR specificity that would result in self-reactivity in mature T cells. Both selection events are mediated by interactions between the TCR and self-peptide͞MHC ligands (2) (3) (4) . Negative selection occurs when the interaction between the TCRs and peptide͞ MHC ligands is strong, and positive selection takes place when the interaction is weak (5, 6) . The strength of the interaction is influenced both by the affinity of the TCR for peptide͞MHC ligand and the abundance of the ligand and, thus, by the avidity of the peptide͞MHC-TCR interactions.
Several recent studies have focused on the relationships between the affinity of peptide͞MHC-TCR interactions, their kinetics, and the effect on the signals transduced by the TCR (7) (8) (9) (10) . These studies have shown that the ''on rate'' of the ligand-receptor interaction is relatively constant, while the ''off rate'' varies widely depending on the specific combination of the ligand and the receptor. Thus, the affinity of the peptide͞MHC-TCR interaction is determined primarily by the dissociation constant; a low-affinity interaction is caused primarily by a high dissociation rate, and a high-affinity interaction is caused by a low dissociation rate.
It was observed that peptide͞MHC-TCR interactions with low dissociation rates often are efficient in mediating T cell activation, while interactions with high dissociation rates can antagonize T cell activation. Peptide͞MHC-TCR interactions with a dissociation rate above a certain threshold have no influence on T cell activation. It is not entirely clear how short-lived peptide͞MHC-TCR interactions antagonize the effects of long-lived interactions. It is possible that short-lived peptide͞MHC-TCR interactions perturb the formation of stable TCR aggregates and͞or mediate incomplete signaling events, causing depletion of downstream signaling molecules (7, 11, 12) .
Many antagonistic peptides and peptides with antagonistic͞ partial agonistic properties seem to be efficient at inducing positive selection of double positive (DP) thymocytes (5), although there is no strict correlation between antagonism and positive selection (8, 13, 14) . However, peptide͞MHC-TCR interactions with dissociation rates above a certain threshold are incapable of mediating positive selection, while those with low dissociation rates tend to result in the production of nonfunctional single positive (SP) thymocytes or negative selection (8, 15, 16) .
To date, the effects of low-affinity peptide͞MHC-TCR interactions on positive and negative selection have been studied mostly in vitro. In this study we used mice transgenic for an influenza NP68 (nucleoprotein 366-374)-specific TCR (F5) (17) . To analyze the effect of an antagonistic peptide on T cell development in vivo, we introduced a transgene encoding the antagonistic variant peptide NP34 fused to the adenovirus E19͞3K signal sequence. The peptide was transported to the endoplasmic reticulum independently of Tap-1 and presented by H-2D b . We analyzed the effects of the transgene in mice with F5 ϩ Rag-1 TCA CAT TGT TTC CAT GTT TTC GTT GCT TGC TGC CGC GCT GCA GAC TGC CGC AAG GGC) that contained a 21-nt overlap, thus serving as each other's template for PCR. PCR was performed using the pfu polymerase (Stratagene). The product was digested with EcoRI, gel-purified, and ligated into the cloning site of pCAGGS. An additional alanine was introduced in the minigene between the E3͞19K signal sequence and the peptide, since it is unknown where the signal peptide is cleaved off exactly. As N-terminal cleavage of additional amino acids can take place in the endoplasmic reticulum, the correct peptide would be produced if the peptide was cleaved at the N-terminal side of the extra alanine (18, 19) . If the cleavage took place more to the C-terminal side than expected, the extra alanine avoids the production of an octameric peptide.
The minigene was excised by SalI and PstI digestion, gelpurified, and microinjected into fertilized F5 ϩ Tap (22) . They were bred and maintained in a pathogen-free environment at the Massachusetts Institute of Technology. Three weeks after birth genomic DNA was prepared from tail tissue, and the presence of the F5 TCR, Tap-1, Rag-1, and NP34 transgene was analyzed by PCR. The primers used were F5: 5Ј-ACA AAT GCT GGT GTC ATC CA, 3Ј-GGG TGG AGT CAC ATT TCT CA; Tap-1: 5Ј-AGG CTC AGC GTG CCA CTA AT, 3Ј-ATT GAA GTT CCT GCG CCT CC; Rag-1: 5Ј-GAT CGA GCT GAA GGC AGA TG, 3Ј-GTC TCT TCC TCT TGA GTC CC; and Neo: 5Ј-CTT GGG TGG AGA GGC TAT TC, 3Ј-AGG TGA GAT GAC AGG AGG TC. Mice were analyzed between 8 and 10 weeks after birth.
Northern Blot Analysis. Mice were anesthetized by using avertin and perfused by using PBS͞1 mM EDTA. Organs were removed and placed on ice immediately. Whole RNA was prepared by using Tri-Reagent (Molecular Research Center, Cincinnati). Fifteen micrograms of RNA per lane was electrophoresed in a 1% agarose formaldehyde denaturing gel and transferred to Zeta-Probe GT membranes (Bio-Rad). Filters were hybridized with a radiolabeled 0.7-kb EcoRI-PstI fragment from the vector used for generating the transgenic mice, and washed blots were assessed by autoradiography.
Cytotoxicity Assay. B6 mice were immunized i.p. with 100 g NP-34 peptide in incomplete Freund's adjuvant. After 9 days, the spleens were removed and single cell suspensions were prepared and stimulated in vitro with irradiated Tap-1 Ϫ͞Ϫ splenocytes loaded with 100 ng͞ml NP-34. After 1 week, the cytotoxic T cells were restimulated in the presence of 15 units͞ml interleukin 2. Five days later, the cytotoxic T cells were used in a chromium release assay as described (23) . Con A-induced splenic lymphoblasts from Tap-1 Ϫ͞Ϫ or Tap-1 Ϫ͞Ϫ NP34 ϩ mice were used as targets and prepared as described previously (23) .
Flow Cytometry. Three-color stainings were performed using fluorescein isothiocyanate or phycoerythrin-labeled anti-CD4, anti-V␤11, or anti-CD69 antibodies (PharMingen) and Tri-Color-labeled anti-CD8 antibodies (Caltag, South San Francisco, CA). The cells were analyzed on a FACScan (Becton Dickinson) using CELLQUEST SOFTWARE (BEC-TON DICKINSON).
TUNEL Assay. Thymuses were embedded in OCT compound (Miles) on dry ice. Four-micrometer sections were prepared and stored at Ϫ80°C. The TUNEL assay was performed as described (24) . In short, sections were fixed in formalin followed by ethanol͞acetic acid (2:1). Endogenous peroxidase activity was blocked with 0.5% H 2 O 2 . Washed sections were incubated for 2 hr at 37°C with biotinylated dUTP (Boehringer Mannheim) and TdT (Promega). After the reaction was blocked, the sections were washed, incubated with avidin-biotinylated peroxidase (Dako), washed again, and developed with 3-amino-9-ethylcarbazole (Aldrich). Twenty different fields were counted per thymus (ϫ40 objective). was expressed highest in heart, gut, and muscle and lowest in the brain. The level of expression in the thymus was intermediate compared with that in other tissues. We did not directly test the possibility that the signal obtained from thymus was derived from lymphoid cells rather than from thymic epithelium. However, the promoter used was a ubiquitous promoter and mediated high expression of the transgene in epithelial tissues such as skin, lung, and intestine. Therefore, it is likely that the transgene was expressed in thymic epithelium.
RESULTS
Presentation of the NP34 Peptide by MHC Class I. Although Northern blot analysis showed ubiquitous expression of the NP34 transgene, we had to ascertain that the NP34 peptide actually was translated and transported to the endoplasmic reticulum in a Tap-1-independent manner and presented by H-2D b . To verify this, cytotoxic T cells recognizing the peptide were isolated from B6 mice immunized with the NP34 peptide and restimulated once in vitro. Subsequently, these cells were assayed for their ability to specifically lyse Con A-induced splenocyte blasts from Tap-1 Ϫ͞Ϫ NP34 transgenic mice, Con A blasts from Tap-1 Ϫ͞Ϫ mice, (negative control), or Con A blasts from Tap mice had no effect on the development of F5 ϩ T cells. There was no change in the number of DP or CD8 ϩ SP thymocytes ( Fig. 2  B and D) , and TCR expression was not up-regulated (Fig. 3 B  and D) . The percentage of CD69 mice expressing a transgene encoding the nominal peptide (NP68) under the control of the same promoter and enhancer sequences. In such mice, extensive negative selection occurred as could be concluded from the low number of thymocytes (2.6 Ϯ 1.1 ϫ 10 7 , average of seven mice from four independent lines) and the increased percentage of CD69 ϩ thymocytes (26.9 Ϯ 1.2%) (data not shown). We observed a 6.5-fold increase of the percentage of DN thymocytes in these mice when compared with F5 (Fig. 4A) . Surprisingly, the presence of the NP34 transgene inhibited the development of CD8 ϩ SP thymocytes (Fig. 2C ) and peripheral CD8 ϩ T cells (Table 1) . Expression of CD69 was observed on only 11% of all thymocytes (Fig. 4 A) . The absolute number of thymocytes was not changed significantly (Fig. 4B) by the presence of the NP34 peptide. We did not observe up-regulation of the TCR on DP thymocytes of F5 ϩ Rag-1 (Fig. 3 A and C) . This does not seem to reflect down-regulation of TCR expression caused by the presence of NP34, because thymocytes that did mature to the CD8 It has been described that superantigens can mediate negative selection of thymocytes at a late stage of their development, just before the thymocytes become single positive (25) . To test the possibility that the NP34 transgene mediated a similar form of negative selection, we compared the phenotype of F5 mice. These mice express the I-E allele, which can present the mtv8͞9 superantigens that delete V␤11 ϩ T cells (26) . We did not directly assess the presence of the mtv superantigens in these mice, but because negative selection and strong TCR down-regulation on residual peripheral T cells occurred, we are confident that the superantigens were present. As shown in Fig. 2E and Table  1 , the numbers of CD8 ϩ thymocytes and T cells indeed were decreased. However, the absolute number of thymocytes was similar to that in control mice (Fig. 4B) , indicating that negative selection took place at a late stage of T cell development. In contrast to F5 
NP34
ϩ thymuses was comparable to that in nonselecting thymuses. It has been reported that apoptosis caused by superantigen-mediated negative selection occurs in the medulla, in contrast to apoptosis by neglect, which takes place in the cortex (27) . However, we found that in all our mice, apoptosis occurred mainly in the cortex. We do not know the reasons for this apparent discrepancy. Several factors may have played a role, such as the altered thymic architecture caused by the Rag-1 deficiency or differences in the relative expression level or the tissue distribution of the superantigens involved. Despite this uncertainty, we maintain that the negative selection mediated by I-E is late as it is not accompanied by significant reduction of the number of DP thymocytes.
DISCUSSION
In this study, we examined the influence of the antagonistic NP34 peptide on positive and negative selection of thymocytes carrying the NP68-specific TCR, F5. For this, we created mice that present the NP34 peptide on H-2D 3.6 Ϯ 1.8 ϫ 10 6 F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ NP34 ϩ 1.4 Ϯ 0.37 ϫ 10 6 0.59 Ϯ 0.47 ϫ 10 6 F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ I-E ϩ 0.9 Ϯ 0.45 ϫ 10 6 0.14 Ϯ 0.095 ϫ 10 6
The NP34 transgene reduces the absolute numbers of CD8 ϩ splenocytes and lymph node cells. Cells from F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ NP34 ϩ , positively selecting F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ , and negatively selecting F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ I-E ϩ lymphoid organs were isolated and counted. Cells were stained with anti-CD8 antibodies and analyzed by FACS. The absolute numbers of CD8 ϩ T cells were calculated by multiplying the total cell number per organ with the percentage of CD8 ϩ cells. Mean numbers of CD8 ϩ T cells from six to eight mice of each genotype are shown. SDs are indicated. with the situation in F5 ϩ Tap-1 Ϫ͞Ϫ mice expressing the nominal NP68 peptide, in which the thymuses showed a 4-to 5-fold reduction in cellularity. Because negative selection mediated by superantigens was shown previously to occur without a reduction of the number of DP cells (25) , it was possible that the NP34 transgene mediated a similar form of negative selection (29) . Alternatively, the presence of the NP34 peptide could have interfered with positive selection of F5 ϩ thymocytes.
To distinguish between these possibilities, we compared the thymuses of F5 ϩ Rag-1 (30) . Furthermore, we observed that the percentage of thymocytes expressing CD69, an early activation marker that is up-regulated upon positive and negative selection events (28, 31, 32) , is lower in F5 ϩ Rag-1 How could the presence of the NP34 peptide inhibit positive selection? The NP34 peptide has been described to antagonize target recognition by mature F5 ϩ cytotoxic T cells and inhibit negative selection of F5 ϩ thymocytes mediated by the NP68 peptide (33) . Therefore, it is not unlikely that the NP34 peptide is able to antagonize positive selection events as well. Data supporting such an idea have been obtained previously from experiments employing fetal thymic organ cultures from transgenic mice carrying a class II-restricted TCR recognizing the moth cytochrome c peptide (34) . Although apoptosis was not assessed directly, the data did support the notion that negative selection was not responsible for the absence of the CD4 ϩ thymocytes. The data presented here indicate that antagonism of positive selection is not limited to thymocytes carrying CD4-restricted TCRs or to in vitro culture conditions.
In view of the results showing that some antagonist peptides are efficient in mediating positive selection, it seems somewhat surprising that an antagonist peptide is capable of antagonizing positive selection. However, it has been shown that the interaction of antagonistic peptide͞MHC ligands with the TCR-CD3 complex can result in partial phosphorylation of CD3. This partially phosphorylated form of CD3 is incapable of recruiting the protein-tyrosine kinase zap-70 (35, 36) . Furthermore, it has been shown that lck does not become activated by engagement of the TCR with antagonistic peptide͞MHC ligands (37) . As lck (38, 39) and zap-70 (40) are both important for positive selection, such processes may explain the inhibition of positive selection by an antagonist peptide.
Taken together, these results implicate that the signal mediating positive selection must be different from the signal resulting in antagonism. This does not necessarily contradict the finding that some antagonistic peptides are able to mediate positive selection. In fact, we do observe that the NP34 peptide can mediate positive selection of F5 ϩ thymocytes in FTOC at relatively high concentrations (Ͼ10 M) (C.N.L. and S.T., unpublished results). As positive selection was not induced in F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 Ϫ͞Ϫ NP34 ϩ mice, it is likely that the concentration of peptide needed for mediating positive selection is higher than that resulting in antagonism of positive selection. This parallels the situation in mature T cells, to which certain peptides act as antagonists at lower concentrations, and as weak agonists at high concentrations (41) .
How is it possible that certain peptides have no agonistic effects on mature T cells whatsoever, but induce the activation events associated with positive selection of thymocytes (5, 8, 42) ? We suggest that this is because of differences between accessory molecules expressed by immature and mature T cells. The coreceptors CD4 and CD8 stabilize already formed TCR͞ligand interactions (43) probably by serial engagement and induction of conformational changes that stabilize the TCR͞ligand complex (44) . This may not be achieved if the TCR͞ligand interaction is too short-lived (45) . It is known that increased expression levels of coreceptors greatly augment the sensitivity of T cells toward low-affinity ligands (13, 45, 46) . Therefore, it is possible that coreceptor engagement is accelerated with increased coreceptor to TCR ratios, thus shifting the threshold for activation events toward peptide͞MHC ligands with higher off-rates. Thymocytes express higher levels FIG. 5 . Reduction of the numbers of apoptotic thymocytes by expression of the NP34 transgene. Sections were prepared from F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ NP34 ϩ , positively selecting F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ , nonselecting F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 Ϫ͞Ϫ , and negatively selecting F5 ϩ Rag-1 Ϫ͞Ϫ Tap-1 ϩ I-E ϩ thymuses and stained using the TUNEL assay. Bars represent mean values of the number of apoptotic cells per cm 2 as examined with a ϫ40 objective in thymuses of three to four mice of each genotype. SDs are indicated.
